Allergan signs up to Editas’ genome editing tech

15th March 2017 Uncategorised 0

Allergan has secured itself exclusive access to Editas Medicine’s genome-editing ocular programmes under a strategic research and development pact between the two firms.

More: Allergan signs up to Editas’ genome editing tech
Source: News